Dataset Information

Impact of cardiac resynchronisation therapy on burden of hospitalisations and survival: a retrospective observational study in the Northern Region of New Zealand.

ABSTRACT:

Objective

Cardiac resynchronisation therapy (CRT) devices have been shown to improve heart failure (HF) symptoms, survival and improve quality of life (QoL). We evaluated the overall impact of CRT on recurrent hospitalisations and survival in real-world patients with HF.

Design

Retrospective observational study.

Setting

Northern region of New Zealand.

Participants

Patients with HF who underwent CRT device implantation in between 2008 and 2014 were followed up for 1?year.

Interventions

CRT.

Primary and secondary outcomes measured

Survival, all-cause hospitalisations, length of stay, from which days alive and out of hospital (DAOH) were calculated.

Results

177patients were included, of whom eight died (4.5%) within 1?year of follow-up. Pre-CRT implantation, 83% of all patients had been hospitalised for a total 248 hospitalisation events. Following CRT, 47 patients (27%) were readmitted to hospital within 1?year (total of 98 admissions; p<0.01 compared with pre-device implant). Length of hospital stay was significantly shorter than in the year prior to CRT implantation at a median of 4 (IQR 2-6) vs 7 (IQR 3.5-10.5) days (p=0.03). An increase in the median number of DAOH was observed from 362 (IQR 355-364) to 365 (IQR 364-365) (p<0.01) after CRT implant. The improvement in DAOH was seen regardless of gender and type of CRT devices. Greater DAOH was also seen in those with non-ischaemic cardiomyopathy and Caucasians.

Conclusion

After CRT implant, patients with HF have greater DAOH with reduction of total hospitalisation and fewer hospital days. These results support CRT devices use as a treatment option for appropriate HF patients. DAOH represents an easily measured, patient-centred endpoint that may reflect effectiveness of interventions in future CRT studies.

SUBMITTER: Looi KL

PROVIDER: S-EPMC6538077 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Impact of cardiac resynchronisation therapy on burden of hospitalisations and survival: a retrospective observational study in the Northern Region of New Zealand.

Looi Khang-Li KL Lever Nigel N Gavin Andrew A Doughty Robert R

BMJ open 20190527 5

<h4>Objective</h4>Cardiac resynchronisation therapy (CRT) devices have been shown to improve heart failure (HF) symptoms, survival and improve quality of life (QoL). We evaluated the overall impact of CRT on recurrent hospitalisations and survival in real-world patients with HF.<h4>Design</h4>Retrospective observational study.<h4>Setting</h4>Northern region of New Zealand.<h4>Participants</h4>Patients with HF who underwent CRT device implantation in between 2008 and 2014 were followed up for 1 y ...[more]

PMID: 31133581

Similar Datasets

Project description:OBJECTIVE:To determine the effect of age and gender on persistence and adherence in patients taking dabigatran for atrial fibrillation. DESIGN:A retrospective observational study over 4 years using refill prescription data from the National Pharmaceutical Database. SETTING:All patients in New Zealand who received dabigatran from July 2011 to September 2015. POPULATION:43?339 people filled at least one prescription of dabigatran. MAIN OUTCOME MEASURES:The proportion of patients with good adherence (treatment available at least 80% of the time), and the proportion at risk of thrombosis (a break in treatment of more than 2?days) measured 6-monthly for 3 years. Medication persistence recorded over 3?years. RESULTS:Persistence was highest in older patients and showed a significant correlation with age (p<0.001); 24% over 70?years had discontinued treatment by 6 months compared with 50% under 50?years. Adherence was highest in the elderly (p<0.001) with 90% of patients over 80?years with good adherence at 12 months compared with 70% in patients aged 50-60?years and less than 60% in those under 50?years. The time at risk of thrombosis showed a similar pattern with 25% below 60?years with inadequate anticoagulation more than 20% of the time. Adherence dropped during the first 18 months of treatment with the most marked fall in those under 50?years. Adherence shows that breaks in treatment are common with 30% of men under 60?years with a break in treatment of at least 28 days during the first 12 months. CONCLUSION:Adherence and persistence correlate with the patient's age. Those over 70?years have high adherence consistent over time whereas younger patients have significantly worse adherence which declines over the first 18 months, with the lowest rate in those under 50?years. Adherence in our study is lower than reported in clinical trials, therefore the benefit of dabigatran in stroke prevention may not be realised in clinical practice especially in younger patients.

Dataset Information

Impact of cardiac resynchronisation therapy on burden of hospitalisations and survival: a retrospective observational study in the Northern Region of New Zealand.

Objective

Design

Setting

Participants

Interventions

Primary and secondary outcomes measured

Results

Conclusion

Publications

Impact of cardiac resynchronisation therapy on burden of hospitalisations and survival: a retrospective observational study in the Northern Region of New Zealand.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets